Since insulin resistance and hepatic steatosis were less pronounced in females initially, it can be assumed that sex-specific factors (effects of estrogens, adiponectin, FGF21, as discussed above) masked the effect of exogenous FGF21. The gene discussed is FGF21; the disease is Insulin resistance.